RR, B., E, V., Y, K., G, K., A, V., B, E., . . . P, G. (2026). Optimizing prostate cancer treatment with MR-guided focused ultrasound: The role of expanded ablation-to-lesion volume ratio. European radiology, 36(6), 5082. https://doi.org/10.1007/s00330-025-12217-5
Chicago Style (17th ed.) CitationRR, Bitton, Vertosick E, Khandwala Y, Korol G, Vickers A, Ehdaie B, Sonn G, and Ghanouni P. "Optimizing Prostate Cancer Treatment with MR-guided Focused Ultrasound: The Role of Expanded Ablation-to-lesion Volume Ratio." European Radiology 36, no. 6 (2026): 5082. https://doi.org/10.1007/s00330-025-12217-5.
MLA (9th ed.) CitationRR, Bitton, et al. "Optimizing Prostate Cancer Treatment with MR-guided Focused Ultrasound: The Role of Expanded Ablation-to-lesion Volume Ratio." European Radiology, vol. 36, no. 6, 2026, p. 5082, https://doi.org/10.1007/s00330-025-12217-5.